Navigation Links
Cinpathogen Brings Together Over 40 Shanghai Area Hospitals at the First Annual Cinpathogen Hematology Conference
Date:12/5/2007

SHANGHAI, China, Dec. 5 /PRNewswire/ -- Representatives from over 40 Shanghai area hospitals, more than double the expected attendance, took part in the first annual Cinpathogen Hematology Conference at Shanghai's Equatorial Hotel. The conference, hosted by Cinpathogen Inc. and chaired by Professor Lin Guowei, Director of the Shanghai Clinical Epidemiology Institute, covered current developments in clinical laboratory medicine and shared valuable findings from the Shanghai Health Study.

"The level of interest in the conference was far beyond what we expected," said Dr. Richard Irons, Laboratory Director and Cinpathogen CEO. "It demonstrates the growing demand for high-quality healthcare delivery and research in China."

The event included presentations by Western and Chinese hematologists and pathologists on recent developments and research findings in the field of clinical diagnosis, hematology, toxicology, and pathology. The research presented was the result of the Shanghai Health Study, a 5-year-long clinical study of Chinese patients with hematopoietic disease, led by Cinpathogen Inc. through its partnership with Fudan University and the extensive cooperation of leading hospitals in Shanghai. Cinpathogen's well-established research relationships have allowed company doctors and scientists to diagnose, collect and characterize over 2000 cases of hematopoietic and lymphoid disease over the last 4 years, resulting in a dozen peer-reviewed publications and one of the world's largest tissue banks dedicated to diseases of the blood and immune system.

Professor Ouyang Renrong, former chairman of both the Chinese Hematology Society and the Shanghai Hematology Society, applauded the accomplishment. "The Shanghai Health Study is one-of-its-kind in China and probably in the world. It is strong evidence of how science can make outstanding contributions to society through an integrated, big sampling approach. Had each hospital in Shanghai focused on its own interest and kept its own samples for its own use, we would have not gained this level of in-depth research findings or the extensiveness of the tissue bank."

Cinpathogen Inc. is a major partner in the Fudan-Cinpathogen Center for Clinical and Molecular Research in the Institute of Biomedical Sciences at Fudan University. Cinpathogen integrates Western and Chinese medical research systems by bringing together clinical operations, modern diagnostic laboratories and access to one of the largest tissue banks dedicated to diseases of the blood and immune systems to support diagnosis and conduct protocol-driven research on the etiology, pathogenesis and treatment of disease.

Cinpathogen reports and publications appear in many peer-reviewed scientific journals, including Leukemia Research, International Journal of Hematology, Proceedings of the American Association for Cancer Research, and Chinese Journal of Oncology.

If you'd like more information about this topic or Cinpathogen, please contact Dr Richard D. Irons at (303) 381-2543 or email him at contact@cinpathogen.com.

http://www.cinpathogen.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Cinpathogen Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
2. Elekta Brings Intelligent Ways to Manage Motion During Cancer Treatment to ESTRO
3. Doping technique brings nanomechanical devices into the semiconductor world
4. Six UK Hospitals Join Together in Using Varian Medical Oncology Information Network
5. The Food Allergy & Anaphylaxis Network (FAAN) and Verus Pharmaceuticals Work Together to Raise Awareness of Food Allergies
6. Shanghai Century Acquisition Corporation Announces Sichuan Kelun Pharmaceutical Co Results for the Six Months Ended June 30, 2007
7. HUYA Bioscience International Licenses Clinical Stage Anti-Arrhythmic Compound from the Shanghai Institute of Materia Medica
8. National Surgical Hospitals Acquires Majority Share of Houston-Area Surgery Center
9. Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals
10. American M.R.I.-DOL: Small Hospitals To Turn The Camera On Themselves In Unique National Contest
11. Hospitals Adopt STERIS Advanced Room Sterilization Technology in the Fight Against Superbugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/9/2017)... Texas (PRWEB) , ... October ... ... study published on October 5, 2017, in the medical journal, Epilepsia, Brain ... with the gold standard, video EEG, in detecting generalized tonic-clonic seizures (GTCS) ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first commercially available Hi-C kit. ... to perform Hi-C metagenome deconvolution using their own facilities, supplementing the company’s ...
(Date:10/6/2017)... (PRWEB) , ... October 06, 2017 , ... ... entrepreneurship within the healthcare and technology sector at their fourth annual Conference where ... featuring 30 inspiring speakers and the ELEVATE pitch competition showcasing early stage digital ...
(Date:10/5/2017)... ... , ... LabRoots , the leading provider of educational and interactive virtual ... to cancer research with a month-long promotion supporting the advancement of breast cancer research ... use promo code PinkRibbon to get 10 percent off their purchase of every the ...
Breaking Biology Technology:
(Date:5/23/2017)... 23, 2017  Hunova, the first robotic gym for the rehabilitation and ... launched in Genoa, Italy . The first 30 robots ... the USA . The technology was developed and patented ... the IIT spin-off Movendo Technology thanks to a 10 million euro investment ... please click: ...
(Date:5/16/2017)... --  Bridge Patient Portal , an enterprise patient ... Systems , an electronic medical record solutions developer ... a partnership to build an interface between the ... products, including Centricity Practice Solution (CPS), Centricity Business ... integrations will allow healthcare delivery networks using GE ...
(Date:4/24/2017)... WASHINGTON , April 24, 2017 ... counsel and partner with  Identity Strategy Partners, LLP ... "With or without President Trump,s March 6, ... Foreign Terrorist Entry , refugee vetting can be instilled ... refugee resettlement. (Right now, all refugee applications are ...
Breaking Biology News(10 mins):